| International Diabetes Management Practices Study (Wave 5) |
Ongoing |
N/A |
4 |
DIREG_R_05941 |
King Fahad Hospital (Jeddah) |
| An observational study to monitor the efficacy and tolerability of levofloxacin 250 mg OD for treatment of simple lower UTI in Saudi Arabia |
Ongoing |
Levofloxacin |
4 |
LEVOF_L_05172 |
Erfan & Bagedo General Hospital (Jeddah) |
| A randomized, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonias (IIP). |
Completed |
Riociguat |
2 |
BAY 63-2521 / 13605 |
King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh) |
| Tracking Biologics Along the Silk Road |
Ongoing |
Infliximab / Golimumab / Ustekinumab |
4 |
C0168ARA40 |
King Khalid University Hospital (Riyadh) |
| The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma orOcular Hypertension. |
Ongoing |
Bimatoprost SR |
3 |
192024-092 |
King Khaled Eye Specialist Hospital (Riyadh), King Abdullah Medical City (Makkah) |
| Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers, An International, Multicenter, Double Blind, Randomized Placebo Controlled Phase 3 trial (ICR-02/ASCOLT) |
Ongoing |
Aspirin |
3 |
ICR-02/ASCOLT |
King Fahad Medical City (Riyadh) |
| Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI) |
Ongoing |
NILOTINIB |
4 |
RC12/052/R |
King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam) |
| Middle East Observational Study in Metastatic Soft Tissue Sarcoma: An epidemiological study on the treatment patterns |
Ongoing |
N/A |
4 |
VEG201319 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A study of the factors predicting radiation exposure to contacts of Saudi patients treated with radioactive iodine (I 131): A preliminary study for patients’ criteria selection for possible high dose I131 therapy on out-patient basis in the future |
Completed |
131 Iodine |
4 |
(version#1) dated 10-Apr-14 |
King Abdullah Medical City (Makkah) |
| (FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients |
Ongoing |
Ultibro breezhaler |
4 |
A3405 V01 |
King Fahad Medical City (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz Medical City NG (Jeddah) |
